Filing Details
- Accession Number:
- 0001179110-11-016881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-19 16:15:48
- Reporting Period:
- 2011-12-15
- Filing Date:
- 2011-12-19
- Accepted Time:
- 2011-12-19 16:15:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1419055 | Ellerbrock Jorgine | C/O Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Senior Vp, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-12-15 | 2,000 | $42.66 | 5,922 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-12-15 | 2,445 | $55.85 | 3,477 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-12-15 | 2,000 | $0.00 | 2,000 | $42.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
22,725 | 2017-02-10 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2011.
- 25% of the shares subject to the stock option vested and became exercisable on February 10, 2011 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.